Cargando…

Fibrin glue as a local drug-delivery system for bacteriophage PA5

Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubalskii, Evgenii, Ruemke, Stefan, Salmoukas, Christina, Aleshkin, Andrey, Bochkareva, Svetlana, Modin, Evgeny, Mashaqi, Bakr, Boyle, Erin C., Boethig, Dietmar, Rubalsky, Maxim, Zulkarneev, Eldar, Kuehn, Christian, Haverich, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376040/
https://www.ncbi.nlm.nih.gov/pubmed/30765740
http://dx.doi.org/10.1038/s41598-018-38318-4
_version_ 1783395482175799296
author Rubalskii, Evgenii
Ruemke, Stefan
Salmoukas, Christina
Aleshkin, Andrey
Bochkareva, Svetlana
Modin, Evgeny
Mashaqi, Bakr
Boyle, Erin C.
Boethig, Dietmar
Rubalsky, Maxim
Zulkarneev, Eldar
Kuehn, Christian
Haverich, Axel
author_facet Rubalskii, Evgenii
Ruemke, Stefan
Salmoukas, Christina
Aleshkin, Andrey
Bochkareva, Svetlana
Modin, Evgeny
Mashaqi, Bakr
Boyle, Erin C.
Boethig, Dietmar
Rubalsky, Maxim
Zulkarneev, Eldar
Kuehn, Christian
Haverich, Axel
author_sort Rubalskii, Evgenii
collection PubMed
description Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications.
format Online
Article
Text
id pubmed-6376040
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63760402019-02-19 Fibrin glue as a local drug-delivery system for bacteriophage PA5 Rubalskii, Evgenii Ruemke, Stefan Salmoukas, Christina Aleshkin, Andrey Bochkareva, Svetlana Modin, Evgeny Mashaqi, Bakr Boyle, Erin C. Boethig, Dietmar Rubalsky, Maxim Zulkarneev, Eldar Kuehn, Christian Haverich, Axel Sci Rep Article Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications. Nature Publishing Group UK 2019-02-14 /pmc/articles/PMC6376040/ /pubmed/30765740 http://dx.doi.org/10.1038/s41598-018-38318-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rubalskii, Evgenii
Ruemke, Stefan
Salmoukas, Christina
Aleshkin, Andrey
Bochkareva, Svetlana
Modin, Evgeny
Mashaqi, Bakr
Boyle, Erin C.
Boethig, Dietmar
Rubalsky, Maxim
Zulkarneev, Eldar
Kuehn, Christian
Haverich, Axel
Fibrin glue as a local drug-delivery system for bacteriophage PA5
title Fibrin glue as a local drug-delivery system for bacteriophage PA5
title_full Fibrin glue as a local drug-delivery system for bacteriophage PA5
title_fullStr Fibrin glue as a local drug-delivery system for bacteriophage PA5
title_full_unstemmed Fibrin glue as a local drug-delivery system for bacteriophage PA5
title_short Fibrin glue as a local drug-delivery system for bacteriophage PA5
title_sort fibrin glue as a local drug-delivery system for bacteriophage pa5
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376040/
https://www.ncbi.nlm.nih.gov/pubmed/30765740
http://dx.doi.org/10.1038/s41598-018-38318-4
work_keys_str_mv AT rubalskiievgenii fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT ruemkestefan fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT salmoukaschristina fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT aleshkinandrey fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT bochkarevasvetlana fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT modinevgeny fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT mashaqibakr fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT boyleerinc fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT boethigdietmar fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT rubalskymaxim fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT zulkarneeveldar fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT kuehnchristian fibringlueasalocaldrugdeliverysystemforbacteriophagepa5
AT haverichaxel fibringlueasalocaldrugdeliverysystemforbacteriophagepa5